Cargando…

Cell growth cycle block of T cell hybridomas upon activation with antigen

Stimulation of antigen-specific T cell hybridomas with the appropriate antigen/MHC combination, at concentrations that resulted in the secretion of the lymphokine interleukin 2, resulted in a dose-dependent decrease in both [3H]thymidine incorporation and cell growth. Flow cytometric studies demonst...

Descripción completa

Detalles Bibliográficos
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1987
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2188264/
https://www.ncbi.nlm.nih.gov/pubmed/3491868
_version_ 1782146367447105536
collection PubMed
description Stimulation of antigen-specific T cell hybridomas with the appropriate antigen/MHC combination, at concentrations that resulted in the secretion of the lymphokine interleukin 2, resulted in a dose-dependent decrease in both [3H]thymidine incorporation and cell growth. Flow cytometric studies demonstrated that stimulation with antigen resulted in a cell cycle block that was most evident at the G1/S border, and mixing studies revealed that bystander T cells of different antigen specificities were not affected. For at least the large majority of T cells, the G1/S cell cycle block appeared to be irreversible after 24 h of exposure to antigen. This cell cycle block may be useful as a rapid and quantitative measure of T cell hybridoma activation, as a means of selecting T cell hybridomas that have functional alterations in the reception of stimulatory signals, and may serve as a model of the induction of tolerance in immature T cells.
format Text
id pubmed-2188264
institution National Center for Biotechnology Information
language English
publishDate 1987
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21882642008-04-17 Cell growth cycle block of T cell hybridomas upon activation with antigen J Exp Med Articles Stimulation of antigen-specific T cell hybridomas with the appropriate antigen/MHC combination, at concentrations that resulted in the secretion of the lymphokine interleukin 2, resulted in a dose-dependent decrease in both [3H]thymidine incorporation and cell growth. Flow cytometric studies demonstrated that stimulation with antigen resulted in a cell cycle block that was most evident at the G1/S border, and mixing studies revealed that bystander T cells of different antigen specificities were not affected. For at least the large majority of T cells, the G1/S cell cycle block appeared to be irreversible after 24 h of exposure to antigen. This cell cycle block may be useful as a rapid and quantitative measure of T cell hybridoma activation, as a means of selecting T cell hybridomas that have functional alterations in the reception of stimulatory signals, and may serve as a model of the induction of tolerance in immature T cells. The Rockefeller University Press 1987-01-01 /pmc/articles/PMC2188264/ /pubmed/3491868 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Articles
Cell growth cycle block of T cell hybridomas upon activation with antigen
title Cell growth cycle block of T cell hybridomas upon activation with antigen
title_full Cell growth cycle block of T cell hybridomas upon activation with antigen
title_fullStr Cell growth cycle block of T cell hybridomas upon activation with antigen
title_full_unstemmed Cell growth cycle block of T cell hybridomas upon activation with antigen
title_short Cell growth cycle block of T cell hybridomas upon activation with antigen
title_sort cell growth cycle block of t cell hybridomas upon activation with antigen
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2188264/
https://www.ncbi.nlm.nih.gov/pubmed/3491868